Ascendis Pharma Long Term Deferred Assets (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

205.83 -9.21 (-4.28%) USD | NASDAQ | Jan 16, 16:00

205.70 -0.13 (-0.06%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	Upgrade
Evaxion AS	--
DBV Technologies SA	--
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	--